Igår höll Prilenia ett webbseminarium med en uppdatering av fas III-studien med Pridopidin. Tack till alla som deltog och ett särskilt tack till våra talare, Michael Hayden, Andrew Feigin, Ralf Reilman och Anne Rosser samt Dina de Sousa för European Huntington Association. Håll ögonen öppna för att se fler evenemang under maj månad för medvetenhet! 
Yesterday, uniQure issued a press release announcing alignment with the US Food and Drug Administration (FDA) on key elements of an accelerated approval pathway for uniQure‘s AMT-130 program in Huntington’s disease. The key takeaways are Läs mer...
Dimitri Poffé is an already known member of the HD Community. After testing positive for Huntington’s Disease, Dimitri embraced a bicycle journey through South America. In this project, called Explore for Huntington, Dimitri visited several Läs mer...
December 2, 2024 – PTC to receive $1.0B in cash at closing –– PTC is eligible to receive up to $1.9B in development, regulatory and sales milestones –– PTC to share profits in the U.S. and tiered double-digit royalties on ex-U.S. net Läs mer...
Swedish 
English 
Arabic 
Bulgarian 
Chinese 
Czech 
Danish 
Dutch 
Estonian 
Finnish 
French 
German 
Greek 
Hungarian 
Indonesian 
Italian 
Japanese 
Latvian 
Lithuanian 
Polish 
Portuguese 
Romanian 
Russian 
Slovak 
Slovenian 
Spanish 
Turkish 
Ukrainian
0 kommentarer